Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001341642-26-000002

Options or other derivatives

  • President and CEO acquired 744,960 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mack David Henry · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-05 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +744,960 744,960 D
Loading xslF345X05/form4-03092026_080314.xml…